• Je něco špatně v tomto záznamu ?

Patient-reported symptoms are a more reliable predictor of the societal burden compared to established physician-reported activity indices in inflammatory bowel disease: a cross-sectional study

B. Decker, J. Tuzil, M. Lukas, K. Cerna, M. Bortlik, B. Velackova, B. Pilnackova, T. Dolezal

. 2023 ; 17 (1) : 99-108. [pub] 20221222

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23004733

BACKGROUND: The societal burden of inflammatory bowel diseases (IBD) is not well documented, and further studies are needed to quantify the costs of the disease state. Thus, the aim was to estimate the societal burden and identify its predictors. METHODS: A cross-sectional questionnaire-based study complemented by objective data from patient medical records was performed for patients with Crohn's disease (CD) and ulcerative colitis (UC). RESULTS: We analyzed data from 161 patients (CD: 102, UC: 59). The overall work impairment reached 15.4%, 11.2% vs. 28.8% without/with self-reported symptoms (p = 0.006). Daily activity impairment was 19.3%, 14.1% vs. 35.6% (p < 0.001). The disability pension rate was 28%, 23% vs. 44% (p = 0.012). The total productivity loss due to absenteeism, presenteeism, and disability amounted to 7,673 €/patient/year, 6,018 vs. 12,354 €/patient/year (p = 0.000). Out-of-pocket costs amounted to 562 €/patient/year, 472 vs. 844 €/patient/year (p = 0.001). Self-reported symptoms were the strongest predictor of costs (p < 0.001). CONCLUSION: We found a high societal burden for IBD and a significant association between patient-reported disease symptoms and work disability, daily activity impairment, disability pensions, and out-of-pocket costs. Physician-reported disease activity is not a reliable predictor of costs except for out-of-pocket expenses.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23004733
003      
CZ-PrNML
005      
20240410140017.0
007      
ta
008      
230418s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1080/17474124.2023.2161047 $2 doi
035    __
$a (PubMed)36537197
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Decker, Barbora $u Institute of Health Economics and Technology Assessment, Prague, Czech Republic $u Department of Pharmacology, Faculty of Medicine, Masaryk University, Brno, Czech Republic $1 https://orcid.org/0000000332050662 $7 xx0316085
245    10
$a Patient-reported symptoms are a more reliable predictor of the societal burden compared to established physician-reported activity indices in inflammatory bowel disease: a cross-sectional study / $c B. Decker, J. Tuzil, M. Lukas, K. Cerna, M. Bortlik, B. Velackova, B. Pilnackova, T. Dolezal
520    9_
$a BACKGROUND: The societal burden of inflammatory bowel diseases (IBD) is not well documented, and further studies are needed to quantify the costs of the disease state. Thus, the aim was to estimate the societal burden and identify its predictors. METHODS: A cross-sectional questionnaire-based study complemented by objective data from patient medical records was performed for patients with Crohn's disease (CD) and ulcerative colitis (UC). RESULTS: We analyzed data from 161 patients (CD: 102, UC: 59). The overall work impairment reached 15.4%, 11.2% vs. 28.8% without/with self-reported symptoms (p = 0.006). Daily activity impairment was 19.3%, 14.1% vs. 35.6% (p < 0.001). The disability pension rate was 28%, 23% vs. 44% (p = 0.012). The total productivity loss due to absenteeism, presenteeism, and disability amounted to 7,673 €/patient/year, 6,018 vs. 12,354 €/patient/year (p = 0.000). Out-of-pocket costs amounted to 562 €/patient/year, 472 vs. 844 €/patient/year (p = 0.001). Self-reported symptoms were the strongest predictor of costs (p < 0.001). CONCLUSION: We found a high societal burden for IBD and a significant association between patient-reported disease symptoms and work disability, daily activity impairment, disability pensions, and out-of-pocket costs. Physician-reported disease activity is not a reliable predictor of costs except for out-of-pocket expenses.
650    _2
$a lidé $7 D006801
650    _2
$a průřezové studie $7 D003430
650    12
$a idiopatické střevní záněty $x diagnóza $7 D015212
650    12
$a Crohnova nemoc $x diagnóza $7 D003424
650    12
$a ulcerózní kolitida $x diagnóza $7 D003093
650    _2
$a hodnocení výsledků péče pacientem $7 D000071066
655    _2
$a časopisecké články $7 D016428
700    1_
$a Tuzil, Jan $u Institute of Health Economics and Technology Assessment, Prague, Czech Republic $u Department of Medical Informatics, First Faculty of Medicine, Charles University, Prague, Czech Republic $1 https://orcid.org/0000000271824010
700    1_
$a Lukas, Milan $u IBD clinical and research center ISCARE a.s, Prague, Czech Republic $u Institute of Medical Biochemistry and Laboratory Medicine, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Cerna, Karin $u IBD clinical and research center ISCARE a.s, Prague, Czech Republic
700    1_
$a Bortlik, Martin $u Gastroenterology Department, Ceske Budejovice Hospital, Ceske Budejovice, Czech Republic $u Department of Internal Medicine, Military University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic $u Institute of Pharmacology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Velackova, Barbora $u Institute of Health Economics and Technology Assessment, Prague, Czech Republic
700    1_
$a Pilnackova, Barbora $u Institute of Health Economics and Technology Assessment, Prague, Czech Republic
700    1_
$a Dolezal, Tomas $u Institute of Health Economics and Technology Assessment, Prague, Czech Republic $u Department of Pharmacology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
773    0_
$w MED00174418 $t Expert review of gastroenterology & hepatology $x 1747-4132 $g Roč. 17, č. 1 (2023), s. 99-108
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36537197 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230418 $b ABA008
991    __
$a 20240410140012 $b ABA008
999    __
$a ok $b bmc $g 1925055 $s 1190942
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 17 $c 1 $d 99-108 $e 20221222 $i 1747-4132 $m Expert review of gastroenterology & hepatology $n Expert Rev Gastroenterol Hepatol $x MED00174418
LZP    __
$a Pubmed-20230418

Najít záznam

Citační ukazatele

Možnosti archivace